HK Stock Market Move | U-PRESID CHINA (00220) rises by more than 3%, company's annual performance announcement imminent.
China Unicom (00220) rose more than 3%, up 2.97% as of the time of publication, reaching 7.98 Hong Kong dollars, with a trading volume of 485.31 million Hong Kong dollars.
U-PRESID CHINA (00220) has risen by more than 3%, and as of the time of writing, it has increased by 2.97% to HK$7.98, with a turnover of HK$48.5531 million.
In terms of news, U-PRESID CHINA previously announced that the company will hold a board meeting on March 4 to approve the annual performance announcement and consider recommending dividend distributions for the company and its subsidiaries until December 31, 2025. Daiwa previously pointed out that competition from fresh beverage and bottled beverage manufacturers is intensifying. With increased channel investment, the beverage business may face cost pressures. CMSC (Hong Kong) has previously stated that the company's dividend yield of 6.5% is increasingly attractive, and if there are signs of stability in the industry competition, it will upgrade the rating to a buy recommendation.
Related Articles

HUTCHMED (00013) initiates global research on PI3K/PIKK-EGFR ATTC candidate drug HMPL-A580 for the treatment of solid tumors.

MEDLIVE (02192) issued a total of 325,000 shares according to the stock purchase plan.

Jiangsu Cowin Biotech(688426.SH): The nine-item respiratory pathogen nucleic acid detection kit (fluorescent PCR method) has obtained the medical device registration certificate.
HUTCHMED (00013) initiates global research on PI3K/PIKK-EGFR ATTC candidate drug HMPL-A580 for the treatment of solid tumors.

MEDLIVE (02192) issued a total of 325,000 shares according to the stock purchase plan.

Jiangsu Cowin Biotech(688426.SH): The nine-item respiratory pathogen nucleic acid detection kit (fluorescent PCR method) has obtained the medical device registration certificate.

RECOMMEND





